Autor: |
Joana Reis, Carlos Fernandes, Hoda Salem, Marta Maia, Cláudia Tomé, Sofia Benfeito, José Teixeira, Paulo J. Oliveira, Eugenio Uriarte, Francesco Ortuso, Stefano Alcaro, Donatella Bagetta, Fernando Cagide, Fernanda Borges |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
European journal of medicinal chemistry. 239 |
ISSN: |
1768-3254 |
Popis: |
The absence of disease modifying drugs in Parkinson's disease therapy urges for new chemical entities acting on relevant PD-associated biological targets. As a result, developing selective and reversible inhibitors targeting MAO-B is still a desirable line of therapeutic research. Within this framework, a small library of chromone derivatives was synthesized and screened towards human monoamine oxidases. Structural modifications on the chromone 3-phenylcarboxamide resulted in potent MAO-B inhibitors with an improved drug-like profile, and for the first time we obtained potent and selective chromone 2-phenylcarboxamides acting in the low nanomolar range. Compounds 5-hydroxy-4-oxo-N-phenyl-4H-chromene-3-carboxamide (38) (IC |
Databáze: |
OpenAIRE |
Externí odkaz: |
|